ࡱ> 87 T8\pAdminage-8 Ba==@d8X@"1Calibri1Calibri1Calibri1Calibri1Calibri1Calibri1Calibri1*h6 Calibri Light1,6Calibri16Calibri16Calibri1Calibri1Calibri1<Calibri1>Calibri1?Calibri14Calibri14Calibri1 Calibri1 Calibri1Calibri1Calibri1 Calibri1Calibri1 Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)                                                                       ff + ) , *     P  P        `            a>     h @   h@ @   `@ @   `@ @   @ @   !@ @   h@ @   h@ @   (@ @   (!@ @   `!@ @   `!@ @   !@ @   !!@ @   h!@ @  "x@ @  "8@ @  "x@ @  "8@ @  "x@ @  "x @ @  ||Tr}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-} 00\);_(*}-} 00\);_(*}A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef ;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L ;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A}  00\);_(*23;_(@_) }A}! 00\);_(*23 ;_(@_) }A}" 00\);_(*;_(@_) }A}# 00\);_(*;_(@_) }A}$ 00\);_(*;_(@_) }A}% 00\);_(*;_(@_) }A}& 00\);_(*;_(@_) }A}' 00\);_(* ;_(@_) }A}( 00\);_(*;_(@_) }}) }00\);_(*;_(@_)    }}* 00\);_(*;_(@_) ??? ??? ??? ???}-}+ 00\);_(*}-}, 00\);_(*}-}- 00\);_(*}-}. 00\);_(*}-}/ 00\);_(*}A}0 a00\);_(*;_(@_) }A}1 00\);_(*;_(@_) }A}2 00\);_(*?;_(@_) }A}3 00\);_(*23;_(@_) }-}4 00\);_(*}}5 ??v00\);_(*̙;_(@_)    }A}6 }00\);_(*;_(@_) }A}7 W00\);_(*;_(@_) }}8 00\);_(*;_(@_)    }}9 ???00\);_(*;_(@_) ??? ??? ??? ???}-}: 00\);_(*}-}; 00\);_(*}U}< 00\);_(*;_(@_)  }-}= 00\);_(*}-}> 00\);_(*}A}? 00\);_(*4;_(@_) }A}@ 00\);_(*4;_(@_) }A}A 00\);_(*4;_(@_) }A}B 00\);_(*4;_(@_) }-}C 00\);_(*}-}D 00\);_(*}A}E 00\);_(*4;_(@_) }A}F 00\);_(*4;_(@_) }-}G 00\);_(*}-}H 00\);_(*}A}I 00\);_(*4;_(@_) }A}J 00\);_(*4;_(@_) }-}K 00\);_(*}-}L 00\);_(*}A}M 00\);_(*4;_(@_) }A}N 00\);_(*4;_(@_) }-}O 00\);_(*}A}P 00\);_(*4;_(@_) }-}Q 00\);_(*}A}R 00\);_(*4;_(@_) }A}S 00\);_(*4;_(@_) /  % 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L˭ % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  L % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23 % 60% - Accent3M( 60% - Accent3 23 % 60% - Accent4M, 60% - Accent4 23f % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23Ў % "Accent1AAccent1 Dr % #Accent2A!Accent2 }1 % $Accent3A%Accent3  % %Accent4A)Accent4  % &Accent5A-Accent5 [ % 'Accent6A1Accent6  pG %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 DTj%Dr2 Heading 2G Heading 2 DTj%?3 Heading 3G Heading 3 DTj%234 Heading 49 Heading 4 DTj% 5InputuInput ̙ ??v% 6 Linked CellK Linked Cell }% 7NeutralANeutral  W%3Normal % 8Noteb Note   9OutputwOutput  ???%????????? ???:$Percent ;Title1Title DTj% <TotalMTotal %DrDr= Warning Text? Warning Text %XTableStyleMedium2PivotStyleLight16`DSheet1  ; SV Tumor typeNAMEp16-low vs.p16-highESNES NOM p-val FDR q-val FWER p-val RANK AT MAX LEADING EDGEPAAD+CASELLA ET AL. SENESCENCE UPREGULATED GENEStags=21%, list=7%, signal=22%MESOtags=23%, list=12%, signal=26%COADREADtags=21%, list=12%, signal=23%BLCAtags=31%, list=16%, signal=36%SKCMtags=15%, list=12%, signal=18%GBMtags=8%, list=3%, signal=8%Supplementary Table 3. Gene Set Enrichment Analysis for CDKN2A-low (p16-low) vs. CDKN2A-high (p16-high) tumors using Casella et al. senescence expression signature.8>PW5 A6f6 ccW PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V~&}"!ᇺ_Ν =r!sh ۴T**~ r׮+JOp'M:kүݭjkh [+wc5(_Zw:Mנ_^F֯A)v[_BJ Pl5 cFZԩnΕ(,cuc;P@$=9K !'> BLra)l)oڣh#CZ&beIĐD7 o߼9{og/^=eVe80_~n&_xw_?zоIwOG,:D?DĒ@!vnu6Y7=B>ı0]hq qޜOM#N\{7Ql9=M f-G8S Ǝ=%IJk 9l,k 4I @ʅH~-tx F]n }L-3CS">i}$CތM\[Ht)#,Ky ? v{"%t#LdM!GQ1w}k׺ O!QL×07c]YfGVvi`> X6I?!aW`=@v hT_"BOwxf(_nڼ UΙJpb/N aZG!jxqÕnAr.:M#߉H|nq7\OVlK:RRlkZha$9릫j}W^eu7=M/3\O//٨iG:3hgL(BO}<ь:g#$.Hxω {!J`4T@UK^vVx:lN:E5L+@2_/uR]ӻLf)낀 c3ĖDug`4 }kaQs/\e^Gn~" 8hGOμNO3b/" tMq]{ N P RRRRRRS OQ ? @ @ @ @ @  M A B Chy?C``AP?CI k?CI k?C?C0@  D E F G(ܿG#Gt&??Gt&??Gjt?~ G@  H A B CWi{?C%e^?C,?C,?CMbX9?~ C@  D A B CYٿC]9iCFqT?CFqT?Cx&1?~ C@  D A B C1Fd?C}AtR)?C+C1?C+C1?C|?5^?~ CD@  D I J  K27Bӿ K2ē KRK)^? KRK)^? KJ@K~@ L@p>@KJ    ;  <3[Content_Types].xmlN0EH?{{ ;[Content_Types].xmlN0EH`4 }ka e^GnggD Oh+'0@Hh| Microsoft Office User Envisage-3Microsoft Macintosh Excel@zw@^՜.+,D՜.+,< PXd lt|  Sheet1Sheet1!Print_Area  Worksheets Named Ranges P,L`p8MSIP_Label_5e4b1be8-281e-475d-98b0-21c3457e5a46_Enabled8MSIP_Label_5e4b1be8-281e-475d-98b0-21c3457e5a46_SetDate7MSIP_Label_5e4b1be8-281e-475d-98b0-21c3457e5a46_Method5MSIP_Label_5e4b1be8-281e-475d-98b0-21c3457e5a46_Name7MSIP_Label_5e4b1be8-281e-475d-98b0-21c3457e5a46_SiteId9MSIP_Label_5e4b1be8-281e-475d-98b0-21c3457e5a46_ActionId<MSIP_Label_5e4b1be8-281e-475d-98b0-21c3457e5a46_ContentBitstrue2021-01-15T19:49:05Z StandardPublic(8b3dd73e-4e72-4679-b191-56da1588712b(e403d19d-aebb-43c5-b022-ecb3340eef840  !"#$%&()*+,-.0123456Root Entry FScWorkbookMSummaryInformation('DocumentSummaryInformation8/